Atlas Trials

Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia

Clinical trial NCT01887587 · TERMINATED

Trial details

NCT number
NCT01887587
Sponsor
Ehab L Atallah
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed or Refractory Acute Lymphoblastic LeukemiaRelapsed or Refractory Lymphoblastic LymphomaMixed Phenotype Acute Leukemia
Start date
2013-06-01
Primary completion
2016-02-29
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.